期刊文献+

幼鼠残肾组织凝血酶敏感蛋白-1介导凝血纤溶与肾纤维化的相关研究 被引量:2

Correlation between thrombospondin-1 mediated thrombofibrinolysis and tubulointerstitial fibrosis in remnant renal tissues of 5/6 nephrectomized young rats
下载PDF
导出
摘要 目的探讨在幼年性慢性进展性肾脏病不同时间点肾组织凝血酶敏感蛋白(TSP)-1表达对肾组织凝血纤溶系统的影响,及其与肾纤维化的相关性。并探讨血管紧张素转换酶抑制剂(ACEI)的干预作用。方法用5/6肾切除残肾幼年大鼠为模型,分为不治疗组、治疗组、假手术组。于实验开始,4、8、12周为时间点,检测体质量、血压、尿蛋白定量(24h)等。用免疫组织化学法检测TSP-1、血浆凝血酶原激活物抑制物(PAI)-1、转化生长因子(TGF)-β1、尿激酶型纤溶酶原激活物(uPA)、组织型纤溶酶原激活物(tPA)的表达趋势。分析上述指标在病变进展过程中的变化特点及相关性。判断ACEI的干预效果。结果不治疗组残肾组织中tPA和uPA的表达较假手术组减少,PAI-1的表达增加。治疗后大鼠残肾组织中tPA、uPA表达明显增加,PAI-1表达明显减少。5/6肾切除大鼠各组残肾组织中TSP-1和TGF-β1的表达较假手术组上调,且呈同步上调趋势,治疗组TSP-1和TGF-β1表达则明显趋于下调,治疗组残肾组织TSP-1表达在组织定位上与肾小球硬化和肾小管间质纤维化趋势呈正相关,TSP-1表达与TGF-β1和PAI-1表达呈明显正相关,与uPA和tPA表达呈负相关。结论TSP-1和TGF-β1是促进肾纤维化的重要因子,TSP-1高表达通过影响tPA、uPA、PAI-1及其平衡导致肾组织凝血纤溶系统平衡发生紊乱而促进病变发展。 Objective To investigate how thrombospondin-1 (TSP-1) expression affects and correlates to the thrombofibrinolysis during progression of chronic renal lesions or tubulointerstitial fibrosis in remnant renal tissues of 5/6 nephrectomy young rats, and to study the efficacy of intervention with angiotensin converting enzyme inhibitor (ACEI). Methods Five sixths nephrectomized (5/6 NX) young rats were used as a classical chronic renal failure model. The rats were randomized into the untreated NX group, ACEI-treated NX group or sham group. At the start of this experiment and at weeks 4, 8 and 12, body weight, blood pressure and 24 h proteinuria of the rats were measured protein expressions of TSP-1, PAI-1, TGF-β1, uPA and tPA in remnant renal tissues were determined using immunohistochemical techniques. Changes in these values and interactions among them were evaluated. Effects of ACEI intervention were also'assessed. Results Immunohistochemical staining of the renal tissue showed lowered expressions of tPA and uPA and increased expression of PAI-1 in untreated NX rats vs sham-operated rats. All NX rats showed simultaneous up-regulation of TSP-1 and TGF-β1 in remnant renal tissues as compared with sham-operated ones. Among rats treated with ACEI, the expression of TSP-1 and TGF-β1 appeared to be down-regulated. Positive correlation was identified between TSP-1 expression and tendency of glomeruloscterosis or tubulointerstitial fibrosis. Moreover, the expression of TSP-I was positively correlated with that of TGF-β1 or PAI-1, and negatively correlated with that of uPA or tPA. Conclusion TSP-1 and TGF-β1 were demonstrated to be major promoters for tubulointerstitial fibrosis. Overexpression of TSP-1 may lead to disordered expressions of tPA, uPA and PAI-1 in renal tissues, which can result in imbalance of thrombofibrinolytic system and progression of renal lesions
出处 《中国药物与临床》 CAS 2009年第10期918-921,共4页 Chinese Remedies & Clinics
基金 山西省科委攻关基金(051094-2) 山西省高校科技研究开发基金(2003103)
关键词 凝血酶敏感蛋白1 细胞外基质 肾炎 间质性 Thrombospondin-1 Extracellular matrix Hephritis interstitial
  • 相关文献

参考文献10

  • 1Tamaki K, Okuda S. Role of TGF-beta in the progression of renal fibrosis. Contrih Nephrol, 2003,139:44-65.
  • 2赵晓华,马宏,李卫卫,武艳,李娟,王亚娟.组织型转谷氨酰胺酶在幼鼠肾间质损伤中的表达及意义[J].中国药物与临床,2009,9(4):307-309. 被引量:3
  • 3Hugo C,Kang DH.Johnson KJ,et al. Sustained expression of thrombospondin-1 is associated with the development of glomerular and tubulointerstitial fibrosis in the remant kidney model. Nephron, 2002,90 (4) :460-470.
  • 4Li JH,Zhu H J, Huang XR,et al. Smad7 inhibits fibrotic effect of TGF-B on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol, 2002,13:1464-1472.
  • 5马宏,王翠玲,刘源,王文英,郝翼中.蛋白尿肾损伤过程中凝血酶敏感蛋白表达的意义[J].中华儿科杂志,2002,40(6):368-369. 被引量:2
  • 6Johnson RJ. Have we ignored the role of oncotic pressure in the pathogenesis of glomerulosclerosis? Am J Kidney Dis,2007,29 (1):147-152.
  • 7Hugo C,Pichler RH,Meek R,et al. Thrombospondin 1 is expressed by proliferating Mesangial cells and is up-regulated by PDGF and b FGF in vivo. Kidney Int,2003,48:1846-1856.
  • 8李卫卫,马宏,赵晓华,武艳,李娟,王亚娟.阿霉素肾病大鼠肾组织P^(65)/Rel-A表达趋势及血管紧张素转换酶抑制剂的干预效应[J].中国药物与临床,2008,8(12):959-962. 被引量:1
  • 9Li XC,Zhuo JL. Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin Ⅱ-induced cardiovascular and renal injury. Curr Opin Nephrol Hypertens, 2008,17 (1):37-43.
  • 10Okado T,Terada Y,Tanaka H,et al. Smad7 mediate stransfoyming growth factor-d-induced apoptosis in mesangial cells. Kidney Int, 2002,62:1178-1186.

二级参考文献17

  • 1刘俊兰,程丽静.转化生长因子β1对人肾间质成纤维细胞组织型转谷氨酰胺酶表达的影响[J].中华肾脏病杂志,2005,21(12):753-755. 被引量:2
  • 2张海燕,李幼姬,侯赛云,祝胜郎,余学清,孔耀中,叶任高.结缔组织生长因子在单侧输尿管梗阻大鼠肾组织中的表达[J].中国病理生理杂志,2006,22(3):427-430. 被引量:10
  • 3李航,熊璟,周全荣.组织型转谷氨酰胺酶与肾间质纤维化的研究现状[J].中国中西医结合肾病杂志,2007,8(2):122-123. 被引量:1
  • 4Drumm K, Gassner B, Silbernagl S, et al, Albumin in tile mg/lrange activates NT-KappaB in renal proximal tubule-derived cell lines via tyrosine kinases and protein kinase C. Eur J Med Res, 2001, 6(6):247-258.
  • 5Sahali D, Pawlak A, Le Gouvello S, et al. Transcriptional and post-transcriptional alterations of IkappaB alpha in aetive minireal-change nephrotic syndrome. J Am Soe Nepbrol, 2001, 12(8): 1648-1658.
  • 6Tamada S, Asai T, Kuwabara N, et al. Molecular mechanisms and therapeutic strategies of chronic renal injury: the role of nuclear factor kappaB activation in the development of renal fibrosis. J Pharmacol Sci, 2006, 100(1):17-21.
  • 7Mezzano SA, Barria M, Droguett MA, et al. Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int, 2001, 60(4):1366-1377.
  • 8Rangan GK, Wang Y, Tay YC, et al. Early administration of PDTC in adriamyein nephropathy: effect on proteinuria, cortical tubulointerstitial injury, and NF-kappaB activation. Ren Fail, 2001, 23(6):773-780.
  • 9Cao Z, Cooper ME. Role of angiotensin Ⅱ in tubulointerstitial injury. Semin Nephrol, 2001, 21(6):554-562.
  • 10Ruiz-Ortega M, Ruperez M, Esteban V, et al. Angiotensin Ⅱ: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant, 2006, 21(1):16-20.

共引文献3

同被引文献14

  • 1姚旻,李玉明.基质金属蛋白酶与高血压肾纤维化研究进展[J].心血管病学进展,2006,27(1):100-103. 被引量:5
  • 2O'Reilly MS,Boehm T,Shing Y,et al. Endostatin:an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997,88 (2) : 277-285.
  • 3Kim YM,Hwang S,Kim YM,et al. Endostatin blocks vasc.ular endothelial growth factor-mediated signaling via direct interaction with KDR/FIk- 1. J Biol Chem, 2002,277 (31 ) : 27872-27879.
  • 4Tanabe K,Maeshima Y,Ichinose K,et al. Endostatin peptide,an inhibitor of angiogenesis,prevents the progression of peritoneal sclerosis in a mouse experimental model. Kidney Int,2007,71: 227-238.
  • 5Chchy MC,Rocha FGG,Tristao VR,et al. Collagen xVm/endo- statin in experimental endotoxemic acute renal failure. Braz .J Med Bio Res, 2009,42 (12) : 1150-1 155.
  • 6Maciel TF,Coutinho EL,Soares D,et al. Eudostatin,an antiangiogenic protein,is expressed in the unilateral ureteral obstaJction mice model. J Nephrol, 2008,21:753-760.
  • 7Di Marco GS,Reuter S,Hillebrand U,et al. The soluble VEGF receptor sFltl contributes to endothelial dysfunction in CKD. J Am Soc Nephrol, 2009,20: 2235-2245.
  • 8Hakroush S,Moeller MJ,Theilig F,et al. Effects of increased re nal tubular vascular endothelial growth factor (VEGF) on fibrosis,cyst formation,and glomerular disease. Am J Pathol,2009, 175 : 1883-1895.
  • 9Rehn M, Veikkola T, Kukk-Valdre E,et al. Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci USA ,2001,98(3) : 1024-1029.
  • 10Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to endstage renal failure. J Am Soe Nephrol, 2006,17: 17-25.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部